| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/27/2001 | EP1109813A1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 06/27/2001 | EP1109809A1 Pyrroloquinolines for treatment of obesity |
| 06/27/2001 | EP1109804A1 Chemokine receptor antagonists and methods of use therefor |
| 06/27/2001 | EP1109795A1 Thiazoline acid derivatives |
| 06/27/2001 | EP1109786A1 Piperidine derivatives |
| 06/27/2001 | EP1109784A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands |
| 06/27/2001 | EP1109777A1 N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/27/2001 | EP1109572A2 Neuroprotection |
| 06/27/2001 | EP1109565A1 Gabab1aa receptor |
| 06/27/2001 | EP1109453A1 Compositions and methods for treatment of mitochondrial diseases |
| 06/27/2001 | EP1061927A4 Composition for reducing serum cholesterol levels |
| 06/27/2001 | EP0718281B1 Cyclohexanediurea derivative and process for producing the same |
| 06/27/2001 | EP0660707B1 Amantadine and related compounds for use in the treatment of peripheral neuropathy |
| 06/27/2001 | CN1301298A Methods for prevention and treatment of cancer |
| 06/27/2001 | CN1301269A Template associated NPY Y2-receptor agonists |
| 06/27/2001 | CN1301162A Method for combating obesity |
| 06/27/2001 | CN1301133A Food products having enhanced cocoa polyphenol content and processes for producing same |
| 06/27/2001 | CN1301131A Dipeptide apoptosis inhibitors and the use thereof |
| 06/27/2001 | CN1300731A 3-methyl-2-butenyl isoguanidine as active hypoglycemic component in Yanzizhang and its preparing process |
| 06/27/2001 | CN1300626A Product for invigorating function of brain |
| 06/27/2001 | CN1300616A Tea for reducing blood fat and lossing weight |
| 06/27/2001 | CN1300606A Medicine for treating diabetes |
| 06/27/2001 | CN1300602A Chinese medicine for reducing cholesterol, biliary calcules and bile viscosity |
| 06/27/2001 | CN1300599A Process for extracting active iodine from kelp |
| 06/27/2001 | CN1300591A Hypoglycemic Chinese medicine 'Yanzizhang' and its preparing process |
| 06/27/2001 | CN1300562A Composition containing fat-soluble vitamins |
| 06/27/2001 | CN1067687C Polymorphic foams of growth hormone secretagogue |
| 06/27/2001 | CN1067685C Pyridazinoquinoline compounds |
| 06/27/2001 | CN1067678C Alkyl heterocyclic compound and preparation method thereof, and medicinal composition containing that kind of compound |
| 06/27/2001 | CN1067562C Chinese medicine for diabetes |
| 06/27/2001 | CN1067550C Calcium receptor active molecules |
| 06/27/2001 | CN1067548C Preparation for beta-carotene or carotene micro capsule and application thereof |
| 06/26/2001 | US6252070 Reacting aryl bromide with butyllithium and zinc bromide to give aryl zinc bromide; reacting with corresponding benzothiazine compound |
| 06/26/2001 | US6252046 Protein for the treatment of kidney defects |
| 06/26/2001 | US6251935 Administration of a racemic alpha-lipoic acid, enantiomers and pharmaceutically acceptable salts, amides, esters or thioester, in reduced or oxidized form as antimigraine agent |
| 06/26/2001 | US6251926 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 06/26/2001 | US6251925 An agonists for human beta-3 adrenoceptor |
| 06/26/2001 | US6251924 Pharmaceutical composition |
| 06/26/2001 | US6251914 Treating cytokine mediated diseases |
| 06/26/2001 | US6251903 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist |
| 06/26/2001 | US6251902 Dipeptide derivatives as growth hormone secretagogues |
| 06/26/2001 | US6251865 Insulin-like growth factor agonist molecules |
| 06/26/2001 | US6251853 Pertussis toxin (ptx); beta-3 subunit of human g protein with not more than six wd repeat motifs; for the diagnosis of disorders, such as a disease associated with g protein dysregulation (i.e. hypertension) |
| 06/26/2001 | US6251433 Polycationic polymers |
| 06/26/2001 | US6251400 Comprising limonin and/or nomilin, and a tocotrienol |
| 06/26/2001 | CA2078871C Cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis |
| 06/24/2001 | CA2329516A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 06/21/2001 | WO2001044497A2 Protein kinase regulation |
| 06/21/2001 | WO2001044489A2 Galactomannan oligosaccharides and methods for the production and use thereof |
| 06/21/2001 | WO2001044485A1 Conjugated fatty acids and related compounds, and method for their enzymatic preparation |
| 06/21/2001 | WO2001044474A1 2871 receptor, a g-protein coupled receptor and methods of use thereof |
| 06/21/2001 | WO2001044473A2 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044448A2 Human oxidoreductase proteins |
| 06/21/2001 | WO2001044295A2 Agonists and antagonists of the receptor gpr19 and their use in appetite control |
| 06/21/2001 | WO2001044284A2 Chimeric natriuretic peptides |
| 06/21/2001 | WO2001044268A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 06/21/2001 | WO2001044260A2 Novel purines |
| 06/21/2001 | WO2001044254A1 Cyclopenteneone derivatives |
| 06/21/2001 | WO2001044248A1 Imidazopyrimidinyl and imidazopyridinyl derivatives |
| 06/21/2001 | WO2001044246A1 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044243A2 Novel heteroaryl-diazabicycloalkanes |
| 06/21/2001 | WO2001044240A1 Antidiabetic thiazolidinediones and their preparation |
| 06/21/2001 | WO2001044239A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | WO2001044227A1 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 06/21/2001 | WO2001044216A1 Trans olefinic glucokinase activators |
| 06/21/2001 | WO2001044213A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/21/2001 | WO2001044206A1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044201A1 Substituted imidazole neuropeptide y y5 receptor antagonists |
| 06/21/2001 | WO2001044200A2 Selective neurokinin antagonists |
| 06/21/2001 | WO2001044170A1 Adamantane derivatives |
| 06/21/2001 | WO2001044164A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 06/21/2001 | WO2001043775A2 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | WO2001043773A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
| 06/21/2001 | WO2001043762A2 Polypeptide compositions with improved stability |
| 06/21/2001 | WO2001043758A1 Nutritional composition, methods of producing said composition and methods of using said composition |
| 06/21/2001 | WO2001043744A1 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
| 06/21/2001 | WO2001043743A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 06/21/2001 | WO2001043723A1 Novel forms of pravastatin sodium |
| 06/21/2001 | WO2001043691A2 Fragments and antagonists of heat shock protein 60 |
| 06/21/2001 | WO2001043540A2 Methods for producing transgenic animals |
| 06/21/2001 | WO2001017955A3 Hydroxyacetamidobenzenesulphonamide derivatives |
| 06/21/2001 | WO2001016136A3 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 06/21/2001 | WO2001008505A9 Methods for suppressing appetite and enhancing exercise and recovery |
| 06/21/2001 | WO2000078972A8 Regulation with binding cassette transporter protein abc1 |
| 06/21/2001 | WO2000074689A8 Unfermented gel fraction from psyllium seed husks |
| 06/21/2001 | WO2000061568A8 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 06/21/2001 | DE19961182A1 Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung Galactomannan oligosaccharides and processes for their preparation and their use |
| 06/21/2001 | DE19957889A1 New nucleic acid encoding triterpenoid-cyclase, useful for producing cyclic triterpenoids and for increasing content of polyunsaturated fatty acids in transgenic organisms |
| 06/21/2001 | CA2551203A1 Novel forms of pravastatin sodium |
| 06/21/2001 | CA2396543A1 Conjugated fatty acids and related compounds, and method for their enzymatic preparation |
| 06/21/2001 | CA2395585A1 Chimeric natriuretic peptides |
| 06/21/2001 | CA2395474A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 06/21/2001 | CA2395088A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | CA2394654A1 Proton pump inhibitors |
| 06/21/2001 | CA2394646A1 Novel purines |
| 06/21/2001 | CA2394640A1 Galactomannan-oligosaccharides and methods for the production and use thereof |
| 06/21/2001 | CA2394600A1 Methods for producing transgenic animals |
| 06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | CA2394504A1 Fragments and antagonists of heat shock protein 60 |